JAK Signaling in Depression and Cognition in Male Football Players
NCT07608796
This study is recruiting at 3 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study is being done to learn more about the role of inflammation in depressive and cognitive symptoms in patients with depression who have played at least 11 years of organized tackle football. This will be evaluated using a medication called baricitinib, which blocks one aspect of inflammation.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Depressive Symptoms
- Cognitive Symptom
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 30 to 55 years
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- Emory University
- Last updated on ClinicalTrials.gov
- September 24, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Georgia · 3
- Emory Clinic, Emory University Hospital · Atlanta, GA
- Emory School Of Medicine · Atlanta, GA
- Emory University · Atlanta, GA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.